Presentations
- July 6, 2023
- June 15, 2023
-
June 12, 2023
Podcast: Sharing Data to Improve Patient-Focused Outcomes
On April 26, 2022, Critical Path Institute’s Dr. Diane Stephenson joined host Alaina Webster to discuss the importance of data sharing to improve patient care, particularly in Neuroscience. Diane and her co-authors recently published a Review, “Can Innovative Trial Designs in Orphan Diseases Drive Advancement of Treatments for Common Neurological Diseases?”, in the April Neuroscience-themed... -
May 3, 2023
Brief TRxA Overview – 15:48
In this video, TRxA Executive Director Maaike Everts and Associate Director Michelle Morgan give viewers a short overview of the C-Path’s Translational Therapeutics Accelerator (TRxA) program. TRxA is a global drug discovery and development program focused on supporting academic scientists in defining optimal strategies for advancing new, cutting-edge therapeutics from the lab to patients. It leverages C-Path’s proficiency in translational and regulatory science to bridge the drug development “valley of death” by providing academic researchers with funding and guidance for the advancement of novel therapeutics from the lab to clinical trials and, ultimately, commercialization and patient care.
View now: https://www.youtube.com/watch?v=ijFTdP4kNDQ
-
April 5, 2023
Critical Path for Rare Neurodegenerative Diseases (CP-RND): An Introduction to the Patient Community
Thank you for your interest in the recent webinar, Critical Path for Rare Neurodegenerative Diseases (CP-RND): An Introduction to the Patient Community. We hope the presentation and conversation with our panelists offered additional insight on the public-private partnership and how we intend to impact drug development for rare neurodegenerative diseases, including ALS. We will continue to have...
